STEP BY STEP, BUILDING STRONGER HEALTHCARE SYSTEMS
The result: a series of pilot programmes that demonstrate the power of concrete solutions to improve the sustainability of healthcare systems. Each programme falls under at least one of the three pillars of sustainable healthcare: prevention and early intervention, patient empowerment and reorganisation of care delivery. The most successful pilots are scaled up and every project proves that even small changes have the potential to make a big impact. The power of pilot programmes is that they serve as examples; models that can be adapted to different countries, languages and health systems.
- Austria – Psoriasis Patient Coaches
- Belgium – Activ84worK
- Canada – Alberta gets Fit for Work
- Denmark – A Solution Catalogue with nine solutions
- Finland – Advancing Healthcare Sustainability
- France – Carmelia
- Germany – The “Simply Irreplaceable!” Initiative
- Greece – Instituting National Health Insurance
- Greece – Re-organising Emergency Hospital Care
- Ireland – A Journey of Innovation & Partnership
- Israel – Reboot – AbbVie Innovation Forum
- Italy – A Micro-Simulation Model
- Netherlands – Towards more Effective Treatments
- Norway – “We Care!” A Work/Life Balance Initiative
- Poland – “Healthy – Active – Constructive”
- Portugal – IS2 Portugal Sustainable Health Initiative
- Romania – The “Hands with Life” Initiative
- Slovakia – A study to facilitate patient education
- Spain – Fit for Life: Living longer, Living Better
- Sweden – A Solutions Catalogue
- Sweden: IBD Home – Patient disease self-monitoring
- Switzerland – Development for Hospitals: A Manual
- Turkey – Gaziantep University Early Arthritis Clinic
- UK – The Hepatitis C Partnership
- UK – The Shared Decision-Making Tool
- UK – Early Intervention Clinic for MSDs
Netherlands – Towards more Effective Treatments
In search of a means to improve the sustainability of our healthcare system, AbbVie Netherlands focused on applying Patient Reported Outcome Measures (PROMs) as one of the key outcome criteria regarding quality of care for RA patients. A White Paper emphasising the advantages of PROMs, along with key stakeholders and an expert roundtable on the impact of PROMs, aimed to leverage the use of PROMs in RA treatment and care in the Netherlands.
PROMs are used to measure the quality of life patients experience in addition to the impact that treatment and care have on quality of life. They provide insights into which outcomes really matter to patients, enabling healthcare providers in partnership with their patients to increase the effectiveness and efficiency of care and treatment.
Using successful examples of current use of PROMs in RA, the White Paper highlights the advantages of using PROMs for patients and healthcare providers by demonstrating how applied PROMs can increase the efficiency of RA treatment.
The challenges facing the implementation of PROMs is that no clear RA-PROMs standard is applied in the Netherlands. Moreover, not all RA centres have the means and infrastructure to implement PROMs, which creates barriers to leveraging PROMs and creating a national standard. By initiating a discussion on these barriers, AbbVie aims to give an incentive to overcome these hurdles and leverage PROMs to a higher level.
The White Paper was launched at an expert panel discussion on PROMs in RA in December 2014, the goal of which was to jointly develop a roadmap to leverage the use of PROMs in RA healthcare in the Netherlands.
The use of PROMs for Rheumatic patients shows that they can improve both effectiveness as well as the efficiency of healthcare. To make RA care and treatment more sustainable, the use of PROMs should be an integral part of treatment options. PROMs create transparency in the quality of healthcare, providing insights in the efficiency and efficacy of treatment and care, leading to a more efficient allocation of resources.
Spotlight on Prevention: When, Who and How?
Unhealthy lifestyles and lack of physical activity are key factors in the development of chronic diseases. Early prevention and diagnosis, better education, and above all collaboration among governments, patient organizations, and industry are crucial to prevent chronic diseases from arising.